Skip to main content

Bicara Therapeutics Inc.

BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002023658

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Bicara Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
3 insiders, $3.48M in total
Insiders trading
3
Net value
−$3.48M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Bicara Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Bicara Therapeutics Inc.
NameTitleLast reported holdingLast filingFilings, past year
Cohlhepp RyanPresident, COO & Interim CEO181,641Sep 10, 202616
Larson JenniferChief Financial Officer–Aug 14, 20261
Hyep IvanChief Financial Officer129,855Aug 12, 202612
Mazumdar ClaireChief Executive Officer362,152Aug 12, 202612
Bender JeremyDirector–Jul 29, 20261
Oliger Christy J.Director–Jul 29, 20261
RA Capital Healthcare Fund LPDirector4,603,418IndirectJun 10, 20262
Ra Capital Management, L.P.Director, 10% Owner4,603,418IndirectJun 10, 20262
Kolchinsky PeterDirector, 10% Owner4,603,418IndirectJun 10, 20262
Shah Rajeev M.Director, 10% Owner4,603,418IndirectJun 10, 20262
RA Capital Nexus Fund III, L.P.Director4,603,418IndirectJun 10, 20262
Powell MichaelDirector–Jun 10, 20261
Bowden ChristopherDirector–Jun 10, 20261
Haviland KateDirector–Jun 10, 20261
Simson JakeDirector–Jun 10, 20261
Robertson Scott M.Director–Jun 10, 20261
Mazumdar-Shaw KiranDirector432,736IndirectJun 10, 20261
Schelman WilliamChief Medical Officer–May 12, 20261
Raben DavidChief Medical Officer55,286Apr 28, 20267
Meisner LaraChief Legal Officer0Feb 4, 20262
Lonberg NilsDirector–Jun 10, 20250
Bonderman DavidOther: Former 10% Owner1,960,425IndirectSep 18, 20240
Coulter James GOther: Former 10% Owner1,960,425IndirectSep 18, 20240
Winkelried JonOther: Former 10% Owner1,960,425IndirectSep 18, 20240
TPG GP A, LLCOther: Former 10% Owner1,960,425IndirectSep 18, 20240
FMR LLCOther: See Remark 11,115,333IndirectSep 18, 20240
FIL LtdOther: See Remark 11,013,853IndirectSep 18, 20240
Deerfield Management Company, L.P.10% Owner, Other: Possible Members of 10% Group897,587IndirectSep 17, 20240
Deerfield Mgmt L.P.10% Owner, Other: Possible Members of 10% Group897,587IndirectSep 17, 20240
Deerfield Partners, L.P.10% Owner, Other: Possible Members of 10% Group897,587IndirectSep 17, 20240
Flynn James E10% Owner, Other: Possible Members of 10% Group897,587IndirectSep 17, 20240
Deerfield Private Design Fund V, L.P.10% Owner, Other: Possible Members of 10% Group897,587IndirectSep 17, 20240
Deerfield Mgmt V, L.P.10% Owner, Other: Possible Members of 10% Group897,587IndirectSep 17, 20240
Biocon Pharma Inc.10% Owner1,080,775IndirectSep 16, 20240
Biocon Ltd10% Owner1,080,775IndirectSep 16, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 10, 2026 (view filing)4:23 PM ETSep 82 daysCohlhepp RyanPresident, COO & Interim CEOSSale−17.5K$22.90−$400.7K−8.8%181.6K after2 lots10b5-1
Aug 12, 2026 (view filing)4:19 PM ETAug 102 daysHyep IvanChief Financial OfficerSSale−12.5K$27.97−$349.6K−8.8%129.9K after10b5-1
Aug 12, 2026 (view filing)4:19 PM ETAug 102 daysMazumdar ClaireChief Executive OfficerSSale−10.0K$27.98−$279.8K−2.7%362.2K after10b5-1
Aug 12, 2026 (view filing)4:19 PM ETAug 102 daysCohlhepp RyanPresident and COOSSale−18.8K$27.98−$524.5K−9.4%181.6K after10b5-1
Jul 14, 2026 (view filing)4:22 PM ETJul 104 daysMazumdar ClaireChief Executive OfficerSSale−10.0K$28.42−$284.2K−2.7%362.2K after2 lots10b5-1
Jul 10, 2026 (view filing)4:10 PM ETJul 8-92 daysCohlhepp RyanPresident and COOSSale−28.8K$28.98−$833.1K−13.7%181.6K after4 lots10b5-1
Jul 10, 2026 (view filing)4:10 PM ETJul 82 daysHyep IvanChief Financial OfficerSSale−28.0K$28.85−$807.7K−17.7%129.9K after3 lots10b5-1
May 26, 2026 (view filing)May 215 daysHyep IvanChief Financial OfficerSSale−9.20K$20.42−$187.9K−6.0%145.4K after10b5-1
May 20, 2026 (view filing)May 182 daysMazumdar ClaireChief Executive OfficerSSale−15.0K$20.04−$300.6K−4.0%362.2K after2 lots10b5-1
May 18, 2026 (view filing)May 153 daysCohlhepp RyanPresident and COOSSale−12.5K$20.29−$253.6K−6.1%191.6K after2 lots10b5-1
Apr 28, 2026 (view filing)Apr 271 dayRaben DavidChief Medical OfficerSSale−5.50K$22.88−$125.8K−9.0%55.3K after10b5-1
Apr 22, 2026 (view filing)Apr 211 dayHyep IvanChief Financial OfficerSSale−9.20K$23.00−$211.6K−6.0%145.4K after10b5-1
Apr 20, 2026 (view filing)Apr 20Same dayMazumdar ClaireChief Executive OfficerSSale−15.0K$23.61−$354.1K−4.0%362.2K after10b5-1
Apr 17, 2026 (view filing)Apr 152 daysCohlhepp RyanPresident and COOSSale−12.5K$23.01−$287.6K−6.0%196.1K after2 lots10b5-1
Mar 26, 2026 (view filing)Mar 251 dayRaben DavidChief Medical OfficerSSale−5.50K$18.95−$104.2K−9.0%55.3K after10b5-1
Mar 24, 2026 (view filing)Mar 231 dayHyep IvanChief Financial OfficerSSale−9.20K$18.52−$170.4K−6.0%145.4K after10b5-1
Mar 20, 2026 (view filing)Mar 18-202 daysMazumdar ClaireChief Executive OfficerSSale−15.0K$18.82−$282.4K−4.2%339.4K after3 lots10b5-1
Mar 17, 2026 (view filing)Mar 161 dayCohlhepp RyanPresident and COOSSale−12.5K$19.66−$245.8K−5.9%200.6K after2 lots10b5-1
Mar 11, 2026 (view filing)Mar 92 daysMazumdar ClaireChief Executive OfficerSSale−36.8K$19.17−$704.8K−9.8%339.4K after10b5-1
Mar 6, 2026 (view filing)Mar 4-62 daysMazumdar ClaireChief Executive OfficerSSale−8.23K$18.74−$154.3K−2.4%339.4K after3 lots10b5-1
Mar 5, 2026 (view filing)Mar 32 daysCohlhepp RyanPresident and COOSSale−17.4K$18.16−$315.8K−7.8%205.1K after2 lots10b5-1
Mar 5, 2026 (view filing)Mar 3-42 daysHyep IvanChief Financial OfficerSSale−16.5K$18.23−$301.0K−10.2%145.4K after2 lots10b5-1
Mar 5, 2026 (view filing)Mar 3-42 daysRaben DavidChief Medical OfficerSSale−16.5K$18.52−$305.6K−23.0%55.3K after2 lots10b5-1
Mar 2, 2026 (view filing)4:22 PM ETFeb 264 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchase+300.0K$16.00+$4.80M+7.0%4.60M after
Mar 2, 2026 (view filing)4:22 PM ETFeb 264 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchase+2.20M$16.00+$35.2M–2.20M afterDerivative
Feb 27, 2026 (view filing)Feb 252 daysCohlhepp RyanPresident and COOSSale−3.63K$18.04−$65.5K−1.7%209.6K after2 lots10b5-1
Jan 26, 2026 (view filing)Jan 224 daysCohlhepp RyanPresident and COOSSale−3.83K$18.10−$69.3K−1.8%210.2K after10b5-1
Jan 26, 2026 (view filing)Jan 224 daysHyep IvanChief Financial OfficerSSale−1.88K$18.15−$34.2K−1.3%145.4K after10b5-1
Jan 20, 2026 (view filing)Jan 155 daysCohlhepp RyanPresident and COOSSale−149$18.02−$2.68K−0.1%214.0K after10b5-1
Dec 23, 2025 (view filing)Dec 221 dayHyep IvanChief Financial OfficerSSale−9.20K$18.31−$168.5K−6.0%145.4K after10b5-1
Dec 16, 2025 (view filing)Dec 151 dayCohlhepp RyanPresident and COOSSale−12.5K$18.68−$233.5K−6.2%189.1K after2 lots10b5-1
Nov 25, 2025 (view filing)Nov 24-251 dayRaben DavidChief Medical OfficerSSale−11.0K$18.65−$205.1K−23.7%35.5K after3 lots10b5-1
Nov 25, 2025 (view filing)Nov 241 dayMazumdar ClaireChief Executive OfficerSSale−41.2K$18.86−$776.3K−11.7%309.9K after10b5-1
Nov 25, 2025 (view filing)Nov 21-244 daysHyep IvanChief Financial OfficerSSale−18.4K$18.54−$341.1K−11.2%145.4K after2 lots10b5-1
Nov 25, 2025 (view filing)Nov 214 daysCohlhepp RyanPresident and COOSSale−12.5K$18.05−$225.6K−6.1%193.6K after2 lots10b5-1
Oct 20, 2025 (view filing)Oct 164 daysMazumdar ClaireChief Executive OfficerSSale−24.1K$18.83−$453.9K−7.2%309.9K after10b5-1
Oct 16, 2025 (view filing)Oct 151 dayCohlhepp RyanPresident and COOSSale−12.5K$18.16−$227.0K−5.9%198.1K after2 lots10b5-1
Oct 15, 2025 (view filing)Oct 13-152 daysMazumdar ClaireChief Executive OfficerSSale−24.7K$18.88−$466.9K−7.4%309.9K after2 lots10b5-1
Oct 10, 2025 (view filing)Oct 91 dayRaben DavidChief Medical OfficerSSale−22.0K$18.45−$405.9K−38.3%35.5K after10b5-1
Oct 10, 2025 (view filing)Oct 91 dayHyep IvanChief Financial OfficerSSale−6.42K$18.23−$116.9K−4.2%145.4K after10b5-1
Oct 8, 2025 (view filing)Oct 6-82 daysHyep IvanChief Financial OfficerSSale−30.4K$18.21−$553.2K−17.3%145.4K after3 lots10b5-1
Oct 8, 2025 (view filing)Oct 6-72 daysCohlhepp RyanPresident and COOSSale−50.5K$18.06−$912.0K−19.9%202.6K after4 lots10b5-1
Oct 1, 2025 (view filing)Sep 292 daysMeisner LaraChief Legal OfficerSSale−33.8K$14.75−$498.7K−100.0%0 after10b5-1
Sep 17, 2025 (view filing)Sep 152 daysMeisner LaraChief Legal OfficerSSale−15.8K$11.49−$181.9K−100.0%0 after10b5-1
Jun 18, 2025 (view filing)Jun 162 daysMeisner LaraChief Legal OfficerSSale−15.8K$10.43−$165.1K−100.0%0 after10b5-1
Mar 18, 2025 (view filing)Mar 144 daysMeisner LaraChief Legal OfficerSSale−79.1K$12.90−$1.02M−100.0%0 after2 lots10b5-1
Sep 18, 2024 (view filing)6:02 PM ETSep 162 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchase+1.83M$18.00+$33.0M+223.7%2.65M after2 lots
Sep 17, 2024 (view filing)6:16 PM ETSep 17Same dayDeerfield Management Company, L.P. and 5 others10% Owner, Other: Possible Members of 10% GroupPPurchase+70.0K$18.00+$1.26M+8.5%897.6K after2 lots